Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

3
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
3
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
Types of RNA01:23

Types of RNA

63.3K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.3K
Antimicrobial Proteins01:23

Antimicrobial Proteins

939
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
939

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Structural basis for sirtuin 2 activity and modulation: Current state and opportunities.

The Journal of biological chemistry·2025
Same author

Proceedings of the second annual dengue endgame summit: A call to action.

PLoS neglected tropical diseases·2025
Same author

The Story behind the Science: On the discovery of respiratory syncytial virus.

mBio·2025
Same author

An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity.

Antiviral research·2024
Same author

Inhibition of SIRT2 promotes death of human cytomegalovirus-infected peripheral blood monocytes via apoptosis and necroptosis.

Antiviral research·2023
Same author

BMaps: A Web Application for Fragment-Based Drug Design and Compound Binding Evaluation.

Journal of chemical information and modeling·2023

相关实验视频

Updated: Jun 9, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

8.2K

针对Sirtuin 2的药物表现出广泛的抗感染活性.

Thomas Shenk1,2, John L Kulp Iii3, Lillian W Chiang1

  • 1Evrys Bio, LLC, Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, PA 18902, USA.

Pharmaceuticals (Basel, Switzerland)
|October 26, 2024
PubMed
概括

调节人体Sirtuin 2 (SIRT2) 的宿主向抗感染药物显示出对各种病原体的承诺. 这些药物提供了一种策略,通过向宿主酶而不是病原体特定产品来克服耐药性.

关键词:
一个SIRT1系统.在SIRT2中,SIRT2是SIRT2.亚洛斯特菌是什么意思?它具有抗感染作用.这是一种抗病毒药物.表观遗传学是指表观遗传学.宿主细胞的新陈代谢主机向的代理人这里是Sirtuin.

更多相关视频

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.8K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K

相关实验视频

Last Updated: Jun 9, 2025

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates
14:32

Deacetylation Assays to Unravel the Interplay between Sirtuins SIRT2 and Specific Protein-substrates

Published on: February 27, 2016

8.2K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

13.8K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.6K

科学领域:

  • 生物化学 生化学
  • 药理学 药理学是指药理学的学科.
  • 传染性疾病 传染性疾病

背景情况:

  • 直接作用的抗感染药物向病原体产品,冒着耐药性的风险.
  • 宿主向剂为克服病原体特定药物的局限性提供了一个替代方案.
  • 人类sirtuin 2 (SIRT2) 是一种NAD+依赖的蛋白质脱酶,主要是细胞质的.

研究的目的:

  • 审查具有抗感染活性的SIRT2调节剂.
  • 探索它们作为抗感染剂的药理机制.
  • 确定未来研究领域,以推进这些代理商的发展.

主要方法:

  • 关于SIRT2调节剂及其抗感染性质的文献综述.
  • 对作用机制的生物化学和X射线结构数据的分析.
  • 检查细胞培养和动物模型数据的疗效.

主要成果:

  • 针对SIRT2的多个小分子抑制RNA/DNA病毒和细胞内细菌.
  • 化合物充当全调节剂,影响多个层次的病原体复制.
  • SIRT2调制剂在细胞培养和动物模型中显示出有效性.

结论:

  • SIRT2调制剂代表了一类有前途的宿主向抗感染药物.
  • 这些药物提供了对抗耐药性感染的潜在策略.
  • 需要进一步的研究来推进SIRT2调节器的临床应用.